Bicycle Therapeutics (BCYC) Form 144: Proposed Sale of 102 Shares

Rhea-AI Filing Summary

Bicycle Therapeutics plc (BCYC) filed a Form 144 notice reporting a proposed sale of 102 shares of common stock through Stifel Nicolaus & Company Inc with an aggregate market value of $872, intended for sale on 10/02/2025 on Nasdaq. The filing discloses that 218 shares were acquired on 10/02/2025 as Restricted Stock Units from the issuer and were paid as equity compensation. The form also reports that the filer sold 411 shares on 07/02/2025 for gross proceeds of $3,058. The notice includes the statutory representation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

• Form 144 was filed, disclosing the proposed sale of 102 shares
• Broker named: Stifel Nicolaus & Company Inc
• Acquisition of 218 shares on 10/02/2025 was via Restricted Stock Units and paid as equity compensation
• Previous sale disclosed: 411 shares sold on 07/02/2025 for $3,058

Negative

• None.

Insights

Securities Compliance Analyst

Form 144 filed to report an insider's proposed sale of 102 shares for $872 on 10/02/2025.

The filing identifies the broker as Stifel Nicolaus & Company Inc and specifies the market where the shares will be sold: Nasdaq. It also documents the acquisition of 218 shares on 10/02/2025 as Restricted Stock Units paid via equity compensation.

The form lists a prior disposition of 411 shares on 07/02/2025 producing $3,058 in gross proceeds. This information is procedural disclosure required under Rule 144 and confirms compliance steps for an insider sale; no additional material facts or regulatory actions are disclosed in the filing.

FAQ

What does Bicycle Therapeutics' (BCYC) Form 144 report?

The form reports a proposed sale of 102 shares of common stock through Stifel Nicolaus with an aggregate market value of $872, to be sold on 10/02/2025 on Nasdaq.

How were the securities that may be sold acquired?

The filing states 218 shares were acquired on 10/02/2025 as Restricted Stock Units from the issuer and paid as equity compensation.

Did the filer sell any BCYC shares recently?

Yes. The filing discloses a prior sale of 411 shares on 07/02/2025 that generated $3,058 in gross proceeds.

Which broker will handle the proposed sale?

The proposed sale lists Stifel Nicolaus & Company Inc as the broker.

On which exchange is the sale intended to occur?

The form specifies the sale is intended to occur on Nasdaq.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 06:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002079922
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BICYCLE THERAPEUTICS PLC
SEC File Number	001-38916
Address of Issuer	BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE UNITED KINGDOM CB21 6GS
Phone	011441223261503
Name of Person for Whose Account the Securities are To Be Sold	Swanton Robert Charles
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	102	872.00	49868567	10/02/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/02/2025	Restricted Stock Units	Issuer			218	10/02/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Charles Swanton Blocks A & B Portway Building Cambridge X0 CB21 6GS	Common Stock	07/02/2025	411	3058.00

144: Remarks and Signature

Remarks
Date of Notice	10/02/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/14/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Robert Charles Swanton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)